Dr. Manel Esteller graduated in Medicine from the Universitat de Barcelona, where he also obtained his Ph.D. degree specialising in molecular genetics of endometrial carcinoma. From 1997 to 2001 Dr. Esteller was a Researcher at the Johns Hopkins University and School of Medicine, (Baltimore, USA) where he studied DNA methylation and human cancer. From 2001 to 2008 Manel Esteller was the Leader of the CNIO Cancer Epigenetics Laboratory. Since October 2008, Dr Esteller is the Director of the Cancer Epigenetics and Biology Program (PEBC) of the Bellvitge Institute for Biomedical Research (IDIBELL) in Barcelona, Professor of Genetics in the School of Medicine of the University of Barcelona, and an ICREA Research Professor. On October 2012, he accepted the position of Director of Strategic Projects at the IDIBELL. His research is devoted to the establishment of the epigenome of cancer cells and the development of epigenetic drugs for therapy. Author of more than three hundred original manuscripts in biomedicine, he is also a Member of numerous international scientific societies, Editorial Boards, reviewer for many journals and funding agencies and recipient of prestigious awards among these the World Health Summit Award for Innovation in Biomedical Research, the European Association for Cancer Research Award and the European Research Council Advanced Grant.
« Go Back